|
MPP5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
1.76439973742504E-10 |
| Normal-vs-Stage3 |
2.17200002428086E-09 |
| Normal-vs-Stage4 |
9.79040000181897E-08 |
| Stage1-vs-Stage2 |
5.788200E-01 |
| Stage1-vs-Stage3 |
6.858800E-01 |
| Stage1-vs-Stage4 |
4.563600E-01 |
| Stage2-vs-Stage3 |
4.538000E-01 |
| Stage2-vs-Stage4 |
7.215200E-01 |
| Stage3-vs-Stage4 |
3.897000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
6.01740879346835E-14 |
| Normal-vs-Asian |
1.386530E-04 |
| Caucasian-vs-AfricanAmerican |
8.307600E-01 |
| Caucasian-vs-Asian |
9.995000E-01 |
| AfricanAmerican-vs-Asian |
9.424400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62458935193399E-12 |
| Normal-vs-Female |
5.31819033255942E-12 |
| Male-vs-Female |
2.051200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.07407441116447E-12 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
2.4846791291111E-13 |
| Normal-vs-Extreme_Obese |
8.07109999945155E-07 |
| Normal_Weight-vs-Extreme_Weight |
8.898400E-01 |
| Normal_Weight-vs-Obese |
1.515770E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.452600E-01 |
| Extreme_Weight-vs-Obese |
4.629900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.657800E-01 |
| Obese-vs-Extreme_Obese |
4.044600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.26800000008498E-07 |
| Normal-vs-Age(41-60Yrs) |
1.57651669496772E-14 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
1.50710000035303E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.545800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.046770E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.197600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.077610E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.731790E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.670200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.22895093680154E-12 |
| Normal-VS-Type2 PRCC |
7.99360577730113E-15 |
| Normal-VS-KIRP CIMP |
2.16429999999601E-05 |
| Normal-VS-Unclassified PRCC |
8.01180000120638E-09 |
| Type1 PRCC-VS-Type2 PRCC |
6.174200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.293200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.603200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.110400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.462400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.522000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.02806652080289E-13 |
| Normal-vs-N1 |
2.66909999657727E-08 |
| Normal-vs-N2 |
1.68455999999262E-05 |
| N0-vs-N1 |
8.523700E-02 |
| N0-vs-N2 |
1.198050E-01 |
| N1-vs-N2 |
7.314400E-02 |
|
|
